Neurotargeting Research Group

Main content


The neurotargeting research group has a broad range of expertise. Advances in molecular neurobiology now provide possibilities for the development of new therapies designed for treatment of neurological and psychiatric disorders. This type of translational research requires competency in both basic molecular research and experience in practical treatment. 

The Neurotargeting Group constitutes one of three groups/labs in the Basic and Translational Neuroscience unit.




The group involves three principal investigators. Please visit their lab pages to learn more about their research.


Jan Haavik (Haavik lab)

Olga Therese Ousdal (Ousdal lab)

Emeritus Anni Vedeler (Vedeler lab)


A new PhD!

Congratulations to Peter on becoming a PhD holder!

PhD defence
Peter Daniel Szigetvari

How is dopamine affected by neurometabolic diseases?

Peter Daniel Szigetvari will defend his PhD degree at the University of Bergen on 14 February 2024 with the thesis "Monoamine synthesis in neurometabolic disorders affecting catecholaminergic functioning".

Prize for young researcher 2022
Olga Therese Ousdal

Congrats to Olga Therese

Olga Therese Ousdal received the award for her research at the intersection between radiology, neurology and psychiatry.

Falch Junior Award

Congrats to Olga Therese

Olga Therese receives the Consul Søren Falch and ophthalmologist Sigurd Falch's junior prize for younger researchers 2022.